Please wait
0001439222AGIOS PHARMACEUTICALS, INC.EX-FILING FEESfalsefalsefalse0.00015310.00015310.0001531 0001439222 2025-03-05 2025-03-05 0001439222 1 2025-03-05 2025-03-05 0001439222 2 2025-03-05 2025-03-05 0001439222 3 2025-03-05 2025-03-05 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
Form
S-8
(Form Type)
Agios Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1—Newly Registered Securities
 
               
Security Type  
Security
Class
Title
  
Fee
Calculation
Rule
  
Amount
Registered (1)
  
Proposed
Maximum
Offering
Price Per
Unit
  
Maximum Aggregate
Offering Price
   Fee Rate  
Amount of
Registration
Fee
               
Equity   Common Stock, $0.001 par value per share   Other   55,374 shares (2)    $33.95 (5)    $1,879,947.30 (5)   
$
153.10
per $1,000,000
   $287.82
               
Equity   Common Stock, $0.001 par value per share   Other   24,300 shares (3)    $33.89 (6)    $823,527.00 (6)   
$
153.10
per $1,000,000
   $126.09
               
Equity   Common Stock, $0.001 par value per share   Other   16,200 shares (4)    $33.89 (6)    $549,018.00 (6)   
$
153.10
per $1,000,000
   $84.06
         
Total Offering Amounts     $3,252,492.30     $497.97
         
Total Fee Offsets         —
         
Net Fee Due               $497.97
(1) In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2) Consists of 55,374 shares issuable under an inducement stock option award granted to Krishnan Viswanadhan, the registrant’s Chief Corporate Development & Strategy Officer, on March 5, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to Mr. Viswanadhan’s entering into employment with the registrant.
(3) Consists of 24,300 shares issuable under an inducement restricted stock unit award granted to Mr. Viswanadhan, the registrant’s Chief Corporate Development & Strategy Officer, on March 5, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to Mr. Viswanadhan’s entering into employment with the registrant.
(4) Consists of 16,200 shares issuable under an inducement performance stock unit award granted to Mr. Viswanadhan, the registrant’s Chief Corporate Development & Strategy Officer, on March 5, 2025, in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to Mr. Viswanadhan’s entering into employment with the registrant.
(5) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(h) of the Securities Act of 1933, as amended. The proposed maximum offering price per share and the maximum aggregate offering price are calculated on the basis of the exercise price of the options outstanding under the inducement stock option award.
(6) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low sale prices of the registrant’s Common Stock as reported on the Nasdaq Global Select Market on March 5, 2025.